Patterns of Opioid and Benzodiazepine Use in Opioid-Naïve Patients with Newly Diagnosed Low Back and Lower Extremity Pain
Authors:
- 12 November 2019
- journal article
- research article
- Published by Springer Nature in Journal of General Internal Medicine
- Vol. 35 (1) , 291-297
Abstract
Background The morbidity and mortality associated with opioid and benzodiazepine co-prescription is a pressing national concern. Little is known about patterns of opioid and benzodiazepine use in patients with acute low back pain or lower extremity pain. Objective To characterize patterns of opioid and benzodiazepine prescribing among opioid-naïve, newly diagnosed low back pain (LBP) or lower extremity pain (LEP) patients and to investigate the relationship between benzodiazepine prescribing and long-term opioid use. Design/Setting We performed a retrospective analysis of a commercial database containing claims for more than 75 million enrollees in the USA. Participants Participants were adult patients newly diagnosed with LBP or LEP between 2008 and 2015 who did not have a red flag diagnosis, had not received an opioid prescription in the 6 months prior to diagnosis, and had 12 months of continuous enrollment after diagnosis. Main Outcomes and Measures Among patients receiving at least one opioid prescription within 12 months of diagnosis, we defined discrete patterns of benzodiazepine prescribing—continued use, new use, stopped use, and never use. We tested the association of these prescription patterns with long-term opioid use, defined as six or more fills within 12 months. Results We identified 2,497,653 opioid-naïve patients with newly diagnosed LBP or LEP. Between 2008 and 2015, 31.9% and 11.5% of these patients received opioid and benzodiazepine prescriptions, respectively, within 12 months of diagnosis. Rates of opioid prescription decreased from 34.8% in 2008 to 27.0% in 2015 (P < 0.001); however, prescribing of benzodiazepines only decreased from 11.6% in 2008 to 10.8% in 2015. Patients with continued or new benzodiazepine use consistently used more opioids than patients who never used or stopped using benzodiazepines during the study period (one-way ANOVA, P < 0.001). For patients with continued and new benzodiazepine use, the odds ratio of long-term opioid use compared with those never prescribed a benzodiazepine was 2.99 (95% CI, 2.89–3.08) and 2.68 (95% CI, 2.62–2.75), respectively. Limitations This study used administrative claims analyses, which rely on accuracy and completeness of diagnostic, procedural, and prescription codes. Conclusion Overall opioid prescribing for low back pain or lower extremity pain decreased substantially during the study period, indicating a shift in management within the medical community. Rates of benzodiazepine prescribing, however, remained at approximately 11%. Concurrent prescriptions of benzodiazepines and opioids after LBP or LEP diagnosis were associated with increased risk of long-term opioid use.Keywords
This publication has 27 references indexed in Scilit:
- Associations of Early Opioid Use With Patient-reported Outcomes and Health Care Utilization Among Older Adults With Low Back PainThe Clinical Journal of Pain, 2018
- Overdose Deaths Involving Opioids, Cocaine, and Psychostimulants — United States, 2015–2016MMWR. Morbidity and Mortality Weekly Report, 2018
- Relationship of Opioid Prescriptions to Physical Therapy Referral and Participation for Medicaid Patients with New-Onset Low Back PainThe Journal of the American Board of Family Medicine, 2017
- Opioid-Prescribing Patterns of Emergency Physicians and Risk of Long-Term UseNew England Journal of Medicine, 2017
- Association Between Initial Opioid Prescribing Patterns and Subsequent Long-Term Use Among Opioid-Naïve Patients: A Statewide Retrospective Cohort StudyJournal of General Internal Medicine, 2016
- Changes in the medical management of patients on opioid analgesics following a diagnosis of substance abusePharmacoepidemiology and Drug Safety, 2016
- Trends in opioid prescribing and co-prescribing of sedative hypnotics for acute and chronic musculoskeletal pain: 2001-2010Pharmacoepidemiology and Drug Safety, 2015
- Prescription Opioid Use Among Disabled Medicare BeneficiariesMedical Care, 2014
- Risks, Management, and Monitoring of Combination Opioid, Benzodiazepines, and/or Alcohol UsePostgraduate Medicine, 2013
- Geographic correlation between large-firm commercial spending and Medicare spending.2010